Abstract
A decreased change in NT-proBNP maybe protective for elderly patients with CHF by improving survival outcomes and preventing severe AKI. However, an excessive decrease in NT-proBNP is a risk factor for the non-recovery of renal function following AKI. Avoiding excessive changes in NT-proBNP may be protective for survival and renal injury prognosis.
Introduction
The heart and kidneys are inextricably linked in what is known as Cardiorenal Syndrome (CRS). In elderly patients with chronic heart failure (CHF), fluid retention often leads to venous congestion or poor arterial perfusion, frequently resulting in Acute Kidney Injury (AKI). Clinicians rely on N-terminal pro-brain natriuretic peptide (NT-proBNP) as a biomarker to assess cardiac stress and volume overload. While reducing these levels through decongestion is a standard therapeutic goal, the impact of aggressive reduction on renal recovery in fragile elderly populations remains a subject of clinical debate. This study investigates how changes in NT-proBNP during an AKI episode predict both 90-day survival and renal recovery.
Methods
Researchers conducted a retrospective cohort study at the Chinese PLA General Hospital in Beijing, analyzing data from 1,160 patients aged 65 or older with a history of CHF who experienced an AKI episode between 2008 and 2018. The study compared NT-proBNP levels at a stable baseline (within 3 months prior to AKI) to levels at the time of AKI diagnosis. Survival was analyzed using Kaplan–Meier curves, and Cox/logistic regression models were employed to adjust for confounders such as age, comorbidities, and medication use.
Key Results
The study revealed a complex relationship between cardiac biomarkers and patient outcomes. Reducing NT-proBNP during an AKI episode was found to be protective for survival, with patients showing a decrease in levels having a 38% lower risk of 90-day mortality (Adjusted HR = 0.62). Furthermore, a decrease in NT-proBNP was associated with a 44% lower risk of progressing to severe AKI (Stages 2 or 3).
However, this survival benefit came with a trade-off: a decrease in NT-proBNP was identified as a risk factor for renal non-recovery. Patients with decreasing levels were 1.59 times more likely to fail to return to baseline kidney function. This effect was particularly pronounced in patients with low baseline NT-proBNP levels (Q1 ≤ 480 pg/mL), suggesting that aggressive decongestion in patients without severe volume overload may lead to "over-diuresis" and subsequent renal damage.
Discussion and Limitations
The findings highlight a "Goldilocks" zone for decongestion in elderly patients. While easing heart strain is vital for survival, excessive reduction in NT-proBNP can starve the kidneys of necessary perfusion. The high 90-day mortality rate of 41.5% underscores the vulnerability of this population.
Limitations of the study include its single-center, retrospective design and a specific cohort (former military members), which may limit generalizability. Additionally, the study lacked detailed imaging for volume status and precise diuretic dosing data. Future prospective trials are needed to establish optimal NT-proBNP reduction targets that balance cardiac relief with renal preservation.
Summary updated